References
- 1. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906–2912.10.1210/jc.2006-059416735483
- 2. Chanson P, Salenave S. Metabolic Syndrome in Cushing’s Syndrome. Neuroendocrinology 2010; 92(suppl 1): 96–101.10.1159/00031427220829627
- 3. Anagnostis P, Athyros VG, Tziomalos K, et al. Clinical Review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009 Aug; 94(8): 2692–701.10.1210/jc.2009-037019470627
- 4. Walker BR. Cortisol--cause and Cure for Metabolic Syndrome? Diabet Med 2006 Dec; 23(12): 1281–8.10.1111/j.1464-5491.2006.01998.x17116176
- 5. Pasquali R, Cantobelli S, Casimirri F, et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993 Aug; 77(2): 341–6.10.1210/jcem.77.2.83938818393881
- 6. Shubeska Stratrova S, Dimitrovski C, Todorovska L, et al. Evaluation of the body composition in female Cushings. J Anthropol Soc Serbia (Novi Sad) 2008; 43: 440–447.
- 7. Neeland IJ, Turer AT, Ayers CR, et al. Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol 2015 May; 65(19): 2150–2151.10.1016/j.jacc.2015.01.061489046525975481
- 8. Borga M, West J, Bell JD, et al. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med 2018 Jun; 66(5): 1–9.10.1136/jim-2018-000722599236629581385
- 9. Neeland IJ, Grundy SM, Li X, et al. Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study. Nutr Diabetes 2016 Jul; 6(7): e221.10.1038/nutd.2016.28497314127428873
- 10. Müller MJ, Geisler C. Defining obesity as a disease. Eur J Clin Nutr 2017; 71: 1256–1258.10.1038/ejcn.2017.15528952604
- 11. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 2017 Jul; 18(7): 715–723.10.1111/obr.1255128489290
- 12. Sharma AM, Campbell-Scherer DL. Redefining obesity: beyond the numbers. Obesity (Silver Spring) 2017 Apr; 25(4): 660–661.10.1002/oby.2180128349662
- 13. Maggi S, Busetto L, Noale M et al. (2015). Obesity: Definition and epidemiology. In A. Lenzi, S. Migliaccio, & L. M. Donini (Eds.), Multidisciplinary approach to obesity: From assessment to treatment. Cham, Switzerland: Springer International Publishing, 31–39.10.1007/978-3-319-09045-0_3
- 14. Shuster A, Patlas M, Pinthus JH et al. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 2012 Jan; 85(1009): 1–10.10.1259/bjr/38447238347392821937614
- 15. Rockall AG, Sohaib SA, Evans D, et al. Computed tomography assessment of fat distribution in male and female patients with Cushing’s syndrome. Eur J Endocrinol 2003 Dec; 149(6): 561–7.10.1530/eje.0.149056114640998
- 16. Laddu DR, Lee VR, Blew RM, et al. Predicting visceral adipose tissue by MRI using DXA and anthropometry in adolescents and young adults. Int J Body Compos Res 2012; 10(4): 93–100.
- 17. Geer EB, Shen W, Gallagher D, et al. MRI assessment of lean and adipose tissue distribution in female patients with Cushing’s disease. Clin Endocrinol (Oxf) October 2010; 73(4): 469–475.10.1111/j.1365-2265.2010.03829.x296267220550536
- 18. Burt MG, Gibney J, Ho KKY. Characterization of the metabolic phenotypes of Cushing’s syndrome and growth hormone deficiency: a study of body composition and energy metabolism. Clin Endocrinol (Oxf) Apr 2006; 64(4): 436–443.10.1111/j.1365-2265.2006.02488.x16584517
- 19. Geer EB, Shen W, Strohmayer E, et al. Body composition and cardiovascular risk markers after remission of Cushing’s Disease: A prospective study using whole-body MRI. J Clin Endocrinol Metab 2012; 97: 1702–1711.10.1210/jc.2011-3123333989022419708
- 20. Shubeska Stratrova S, Kostova E, Janicevic Ivanovska D, et al. Body fat distribution changes during weight loss determined by DXA android/ gynoid indexes of abdominal obesity. Physioacta 2019; 33(2): 9–18.
- 21. Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord 2002 Jul; 26(7): 984–93.10.1038/sj.ijo.080196812080454
- 22. Garrapa GG, Pantanetti P, Arnaldi G, et al. Body composition and metabolic features in women with adrenal incidentaloma or Cushing’s Syndrome. J Clin Endocrinol Metab. 2001; 86(11): 5301–5306.10.1210/jcem.86.11.8059
- 23. Ribeiro-Filho FF, Faria AN, Azjen S, et al. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res December 2003 Dec; 11(12): 1488–1494.10.1038/oby.2003.19914694213
- 24. Choi YJ, Seo YK, Lee EJ, Chung YS. Quantification of visceral fat using dual-energy x-ray absorptiometry and its reliability according to the amount of visceral fat in Korean adults. J Clin Densitom 2015 Apr-Jun; 18(2): 192–7.10.1016/j.jocd.2015.02.00125937307
- 25. Salamone LM, Fuerst T, Visser M. Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol 2000; 89(1): 345–52.10.1152/jappl.2000.89.1.34510904070
- 26. Brownbill RA, Ilich JZ. Measuring body composition in overweight individuals by dual energy x-ray absorptiometry. BMC Med Imaging 2005; 5: 1.10.1186/1471-2342-5-1107984715748279
- 27. Measurement of soft tissue composition by dual energy X-ray absorptiometry. Br J Nutrit 1997; 77(2): 151–163.10.1079/BJN199700219135364
- 28. Denton N, Karpe F. Measuring body composition and regional fat mass accurately. Practical diabetes 2016; 33(7): 224–226.10.1002/pdi.2043
- 29. Kullberg J, Brandberg J, Angelhed JE, et al. Whole-body adipose tissue analysis: comparison of MRI, CT and dual energy X-ray absorptiometry. Br J Radiol 2009 Feb; 82(974): 123–30.10.1259/bjr/8008315619168691
- 30. Ladeiras-Lopes R, Sampaio F, Bettencourt N, et al. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol (Engl Ed) 2017 May; 70(5): 331–337.10.1016/j.rec.2016.09.01027765543
- 31. Lopes HF, Correa-Giannella ML, Consolim-Colombo FM, et al. Viseral adiposity syndrome. Diabetol Metab Syndr 2016; 8(40): B4–B12.10.1186/s13098-016-0156-2495071027437032
- 32. Ibrahim Q, Ahsan M. Measurement of Visceral Fat, Abdominal Circumference and Waist-hip Ratio to Predict Health Risk in Males and Females. Pakistan J Biol Sci 2019; 22: 168–173.10.3923/pjbs.2019.168.17331930817
- 33. Hunter HL, Nagy TR. Body composition in a seasonal model of obesity: longitudinal measures and validation of DXA. Obes Res 2002 Nov; 10(11): 1180–1187.10.1038/oby.2002.16012429883
- 34. Shubeska-Stratrova S. Densitometric to anthropometric indexes of visceral obesity relations. J Anthropol Society of Serbia (Novi Sad) 2011; 46: 49–58.
- 35. Shubeska-Stratrova S. Dual-energy x-ray absorptiometry assessment of the body composition and body fat distribution in pre- and postmenopausal women. J Anthropol Soc Serbia (Novi Sad) 2010; 45: 199–206.
- 36. Shubeska Startrova S. Dual-energy x-ray absorptiometry assessment of the body composition in obese women. J Anthropol Soc Serbia (Novi Sad) 2009; 44: 455–461.
- 37. Kim JS, Yoo SM, Kim KN, et al. Comparison of DXA and CT for truncal obesity in adult women related to metabolic complications. J Korean Acad Fam Med 2007 Sep; 28(9): 675–681.